AstraZeneca Annual Report and Form 20-F Information 2008

Group financial record

Download Excel table (see terms of use page)

For the year ended 31 December	2004 $m	2005 $m	2006 $m	2007 $m	2008 $m
Revenue and profits Revenue	21,426	23,950	26,475	29,559	31,601
Cost of sales	(5,193)	(5,356)	(5,559)	(6,419)	(6,598)
Distribution costs	(177)	(211)	(226)	(248)	(291)
Research and development	(3,467)	(3,379)	(3,902)	(5,162)	(5,179)
Selling, general and administrative costs	(8,268)	(8,695)	(9,096)	(10,364)	(10,913)
Other operating income and expense	226	193	524	728	524
Operating profit	4,547	6,502	8,216	8,094	9,144
Profit on sale of interest in joint venture	219	–	–	–	–
Finance income	532	665	888	959	854
Finance expense	(454)	(500)	(561)	(1,070)	(1,317)
Profit before tax	4,844	6,667	8,543	7,983	8,681
Taxation	(1,161)	(1,943)	(2,480)	(2,356)	(2,551)
Profit for the period	3,683	4,724	6,063	5,627	6,130
Attributable to: Equity holders of the Company	3,664	4,706	6,043	5,595	6,101
Minority interests	19	18	20	32	29
Earnings per share Earnings per $0.25 Ordinary Share (basic)	$2.18	$2.91	$3.86	$3.74	$4.20
Earnings per $0.25 Ordinary Share (diluted)	$2.18	$2.91	$3.85	$3.73	$4.20
Dividends	$0.835	$1.025	$1.410	$1.750	$1.900
Return on revenues Operating profit as a percentage of revenues	21.2%	27.2%	31.0%	27.4%	28.9%
Ratio of earnings to fixed charges	93.6	85.6	92.7	15.6	13.5

At 31 December	2004 $m	2005 $m	2006 $m	2007 $m	2008 $m
Balance sheet Property, plant and equipment, goodwill and intangible assets	11,147	9,697	11,657	29,649	29,240
Other investments	262	256	119	182	156
Deferred tax assets	1,218	1,117	1,220	1,044	1,236
Current assets	13,025	13,770	16,936	17,082	16,152
Total assets	25,652	24,840	29,932	47,957	46,784
Current liabilities	(6,587)	(6,839)	(9,447)	(15,187)	(13,320)
Non-current liabilities	(4,568)	(4,310)	(5,069)	(17,855)	(17,404)
Net assets	14,497	13,691	15,416	14,915	16,060
Share capital	411	395	383	364	362
Reserves attributable to equity holders	13,993	13,202	14,921	14,414	15,550
Minority equity interests	93	94	112	137	148
Total equity and reserves	14,497	13,691	15,416	14,915	16,060

For the year ended 31 December	2004 $m	2005 $m	2006 $m	2007 $m	2008 $m
Cash flows Net cash inflow/(outflow) from:  Operating activities	4,817	6,743	7,693	7,510	8,742
Investing activities	970	(1,182)	(272)	(14,887)	(3,896)
Financing activities	(2,761)	(4,572)	(5,366)	6,051	(6,362)
	3,026	989	2,055	(1,326)	(1,516)

Ratio of earnings to fixed charges

For the purpose of computing these ratios, earnings consist of the income from continuing ordinary activities before taxation of Group companies and income received from companies owned 50% or less, plus fixed charges. Fixed charges consist of interest on all indebtedness, amortisation of debt discount and expense and that portion of rental expense representative of the interest factor.

Back to the top